Lirum Therapeutics, Inc (NASDAQ:LRTX) IPO will take place May, 10 on the NASDAQ exchange under the ticker LRTX.
The company is offering shares at an expected price between $10.00 and $12.00 per share with an insider lock-up period of 180 days ending on November 06, 2024.
See also: Benzinga IPO Calendar
About Lirum Therapeutics, Inc
Lirum Therapeutics, Inc are an innovative, clinical stage biopharmaceutical company focused on the treatment of debilitating diseases through the acquisition, development and commercialization of novel drug candidates with compelling mechanisms of action, regulatory pathways and commercial opportunities
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.